NGK SPARK PLUG-backed Caire, an oxygen equipment manufacturer, agreed to acquire MGC Diagnostics, a company in the cardiorespiratory diagnostics sector. Financial terms were not disclosed. “CAIRE is firmly committed to driving future growth by expanding our offerings in the clinical setting to better serve those individuals affected by cardiorespiratory diseases. MGC has a state-of-the-art portfolio that is widely adopted to diagnose respiratory disease and to ensure that the information obtained benefits disease management. These tools are an excellent complement to CAIRE’s complete range of oxygen therapy solutions,” Earl Lawson, Caire President and CEO.